Innoforce and dMed Team Up to Develop/Manufacture Novel Biologics

Innoforce, a company building a biopharma production facility in Hangzhou , formed a partnership with China-US clinical CRO dMed. The two companies will work together to develop innovative therapeutics from third-parties. Innoforce calls itself a PDMO -- a Partner Development and Manufacturing Organization. The two companies will form partnerships with third-party companies to provide capital, manufacturing and marketing expertise, especially for China-headed biopharma products but also for global markets. More details.... Share this with colleagues: // //